Ihsan Balkaya, MD
Pain Medicine · Norfolk, NENPI 1821592825
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,556 of the $9,820 with a category attached, or 66.8%. 16 manufacturers reported payments, led by Abbott at 35.7% of the total. Reporting peaked in 2023 at $4,000 and has fallen 68.9% since, to $1,243 in 2025.
Across 124 payments — averaging $79.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$3K
- Boston Scientific$2K
- MML US, Inc.$731
- AbbVie$402
- SPR Therapeutics, Inc$215
- plus $649 from 10 others
What the payments were for
- Grants$531%
- Travel & lodging$6,55667%
- Food & beverage$3,21233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $3,507 |
| Medtronic | 27 | $2,659 |
| Boston Scientific | 18 | $1,657 |
| MML US, Inc. | 3 | $731 |
| AbbVie | 22 | $402 |
| SPR Therapeutics, Inc | 6 | $215 |
| Vertos Medical, Inc. | 2 | $165 |
| Nevro Corp. | 1 | $148 |
| Vertex | 5 | $94 |
| Si-bone, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $51 |
| Relievant Medsystems, Inc. | 2 | $34 |
| Bioventus LLC | 1 | $24 |
| Forte Bio-pharma LLC | 1 | $23 |
| Averitas Pharma Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,905
- INTELLIS ADAPTIVESTIM$2,055
- Intracept$1,169
- ReActiv8$680
- mild Device Kit$150
- Senza$148
How this compares
$9,820 in reported general payments places this provider in the 70th percentile of 31 pain medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 104 | $2,691 |
| Gabapentin | 105 | $1,319 |
| Naloxone Hcl | 16 | $1,118 |
| Pregabalin | 34 | $852 |
| Fentanyl | 11 | $828 |
| Lidocaine | 11 | $810 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $602 |
| Celecoxib | 26 | $557 |
| Oxycodone Hcl | 37 | $556 |
| Tramadol Hcl | 65 | $433 |
| Baclofen | 39 | $392 |
| Duloxetine Hcl | 23 | $302 |
| Nortriptyline Hcl | 35 | $283 |
| Cyclobenzaprine Hcl | 17 | $163 |
| Tizanidine Hcl | 20 | $130 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Norfolk
- James BertusNorfolk$4K
- Phillip EssayLincoln$63K
- Austin ReillyElkhorn$34K
- Charles WhittenLincoln$25K
- Matthew StottleOmaha$14K
- John MasseyLincoln$13K
- Liane DonovanLincoln$13K
- Katie BerkyOmaha$12K
- Dongyup LeeGrand Island$11K
- Tyrus SoaresOmaha$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.